Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Study estimates worldwide Alzheimer market will surpass $3B by 2009
March 22nd, 2004
With the worldwide prevalence of Alzheimer disease estimated at more than 15.3 million people in 2004 (based on U.S. Census Bureau data and epidemiology studies), Navigant Consulting, Inc., (NCI) Front Line Strategic Market Reports analysts have determined there is increasing demand for effective therapeutics to delay disease progression and improve the quality of life for patients. In their recently concluded study entitled "Emerging Alzheimer's Disease Therapeutics: Physician Perspectives and Competitive Benchmarking Analysis of a High Growth Market," the analysts also determined that there will be tremendous revenue expansion in this neurodegenerative disease segment...
Source: Health & Medicine Week (2004-03-22)
|
